BioActs
Latest round
- Series B
Last raised
- Jul 2017
Total raised
- $3.1M
Investors
- 3
About BioActs
Established in 1976 and based in South Korea, BioActs is a research and development company that focuses on the development of fluorescent materials and optical contrast agents. In 2005, the company started producing antibacterial dyes and blue fluorescent OLED material. In 2009, the company established the biological division. In 2016, the company changed its name to BioActs. Jong Joo Na, the CEO of the company, was the CEO of DKC Corporation. The company's main products include fluorescent dyes, optical contrast agent, fluorescent antibodies, magnetic beads, and dye labeling kit, etc. Optical contrast agents are used in animal model studies. The company's products are used in the fields of biomedicine and pharmaceuticals.
Who invested in BioActs
3 investors across 1 round
See all investors in BioActs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 1, 2017
Amount
$3.1M
Investors
Questions about BioActs
Who invested in BioActs?
BioActs has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioActs raised?
BioActs has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioActs last raise money?
BioActs's most recent round on record is a Series B, in Jul 2017.
What does BioActs do?
Established in 1976 and based in South Korea, BioActs is a research and development company that focuses on the development of fluorescent materials and optical contrast agents.
Where is BioActs headquartered?
BioActs is headquartered in Incheon, South Korea.
Which VCs invest in companies like BioActs?
Among active investors with capital left to deploy, Yufu Capital, ICBC Capital Management, Ningbo Tongshang Fund and Boc Private Equity Firm back materials companies at BioActs's stage. Their profiles are linked below.
VCs backing materials startups at Series B
Raising like BioActs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.